GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (NAS:PACB) » Definitions » E10

Pacific Biosciences of California (Pacific Biosciences of California) E10 : $-0.91 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Pacific Biosciences of California E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.91 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 4.00% per year. During the past 5 years, the average E10 Growth Rate was 51.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pacific Biosciences of California was 66.20% per year. The lowest was 4.00% per year. And the median was 62.50% per year.

As of today (2024-04-27), Pacific Biosciences of California's current stock price is $1.47. Pacific Biosciences of California's E10 for the quarter that ended in Dec. 2023 was $-0.91. Pacific Biosciences of California's Shiller PE Ratio of today is .


Pacific Biosciences of California E10 Historical Data

The historical data trend for Pacific Biosciences of California's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California E10 Chart

Pacific Biosciences of California Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.60 -1.03 -0.94 -0.93 -0.91

Pacific Biosciences of California Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.93 -0.93 -0.93 -0.92 -0.91

Competitive Comparison of Pacific Biosciences of California's E10

For the Medical Devices subindustry, Pacific Biosciences of California's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Shiller PE Ratio falls into.



Pacific Biosciences of California E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.31/129.4194*129.4194
=-0.310

Current CPI (Dec. 2023) = 129.4194.

Pacific Biosciences of California Quarterly Data

per share eps CPI Adj_EPS
201403 -0.280 99.695 -0.363
201406 -0.270 100.560 -0.347
201409 -0.130 100.428 -0.168
201412 -0.260 99.070 -0.340
201503 -0.270 99.621 -0.351
201506 -0.160 100.684 -0.206
201509 0.020 100.392 0.026
201512 -0.020 99.792 -0.026
201603 -0.230 100.470 -0.296
201606 -0.210 101.688 -0.267
201609 -0.190 101.861 -0.241
201612 -0.200 101.863 -0.254
201703 -0.260 102.862 -0.327
201706 -0.260 103.349 -0.326
201709 -0.190 104.136 -0.236
201712 -0.180 104.011 -0.224
201803 -0.200 105.290 -0.246
201806 -0.170 106.317 -0.207
201809 -0.190 106.507 -0.231
201812 -0.210 105.998 -0.256
201903 -0.200 107.251 -0.241
201906 -0.160 108.070 -0.192
201909 -0.190 108.329 -0.227
201912 -0.001 108.420 -0.001
202003 0.010 108.902 0.012
202006 -0.150 108.767 -0.178
202009 -0.140 109.815 -0.165
202012 0.370 109.897 0.436
202103 -0.450 111.754 -0.521
202106 -0.210 114.631 -0.237
202109 0.080 115.734 0.089
202112 -0.310 117.630 -0.341
202203 -0.370 121.301 -0.395
202206 -0.320 125.017 -0.331
202209 -0.340 125.227 -0.351
202212 -0.370 125.222 -0.382
202303 -0.360 127.348 -0.366
202306 -0.280 128.729 -0.282
202309 -0.260 129.860 -0.259
202312 -0.310 129.419 -0.310

Add all the adjusted EPS together and divide 10 will get our e10.


Pacific Biosciences of California  (NAS:PACB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pacific Biosciences of California E10 Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California (Pacific Biosciences of California) Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.
Executives
Oene Mark Van officer: Chief Operating Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Christian O Henry director 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
David W Meline director 3M COMPANY, 3M OFFICE OF GENERAL COUNSEL, ST PAUL MN 55144-1000
Susan G. Kim officer: Chief Financial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Jeff Eidel officer: See Remarks 1305 O'BRIEN DR., MENLO PARK CA 94025
Michele Farmer officer: Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
William W. Ericson director 777 MARINERS ISLAND BOULEVARD, SUITE 550, SAN MATEO CA 94404
Peter Fromen officer: Chief Commercial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Hannah Valantine director 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Michael Hunkapiller director 400 HAMILTON AVENUE, 4TH FLOOR, PALO ALTO CA 94301
Eric Schaefer officer: VP Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Kathy Ordonez director 3 GIRALDA FARMS, C/O QUEST DIAGNOSTICS, MADISON NJ 07940
Randall S Livingston director
Lucy Shapiro director 10210 GENETIC CENTER COURT, SAN DIEGO CA 92121
David Botstein director 1380 WILLOW ROAD, PACIFIC BIOSCIENCES OF CALIFORNIA INC, MENLO PARK CA 94025